Effects of medium-term PUVA therapy on peripheral T-lymphocyte subsets in sporiatic patients

G. Borroni, V. Brazzelli, A. Fietta, M. Gatti, M. Bellosta, G. Vignati, C. Zaccone, E. Berardesca, G. Rabbiosi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Three to four months' PUVA treatment is a widely-adopted procedure to induce psoriasis remission and for the purpose of this study is called 'medium-term'. The 32 psoriatic patients considered revealed a statistically significant baseline decrease in OKT3 + (p <0.001), OKT4 + (p <0.001) and OKT8 + (p <0.001) as compared with 40 healthy controls, while OKT4/OKT8 was normal. Variance analysis within the psoriatic group failed to reveal further significant variation in the immunological parameters during the 3 months under study. Nevertheless, there was a marked trend towards a reduction in OKT4 + cells and OKT4/OKT8 as compared with baseline values after 3 months. These results suggest that 'medium-term' PUVA therapy does not statistically restore the pre-existing baseline changes in T-lymphocyte subsets of the psoriatic patients. The non-statistically significant effects as regards OKT4 + may be due to the small number of patients who reached 3 months' treatment (9 patients) but could be regarded as the first step towards the significant changes described here in long-term PUVA-treated psoriatic patients.

Original languageEnglish
Pages (from-to)125-129
Number of pages5
JournalActa Dermato-Venereologica, Supplement
Volume69
Issue number146
Publication statusPublished - 1989

Fingerprint

PUVA Therapy
T-Lymphocyte Subsets
Muromonab-CD3
Psoriasis
Analysis of Variance
Therapeutics

Keywords

  • Blood T-lymphocyte subpopulations
  • Psoriasis
  • PUVA-therapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Effects of medium-term PUVA therapy on peripheral T-lymphocyte subsets in sporiatic patients. / Borroni, G.; Brazzelli, V.; Fietta, A.; Gatti, M.; Bellosta, M.; Vignati, G.; Zaccone, C.; Berardesca, E.; Rabbiosi, G.

In: Acta Dermato-Venereologica, Supplement, Vol. 69, No. 146, 1989, p. 125-129.

Research output: Contribution to journalArticle

Borroni, G, Brazzelli, V, Fietta, A, Gatti, M, Bellosta, M, Vignati, G, Zaccone, C, Berardesca, E & Rabbiosi, G 1989, 'Effects of medium-term PUVA therapy on peripheral T-lymphocyte subsets in sporiatic patients', Acta Dermato-Venereologica, Supplement, vol. 69, no. 146, pp. 125-129.
Borroni, G. ; Brazzelli, V. ; Fietta, A. ; Gatti, M. ; Bellosta, M. ; Vignati, G. ; Zaccone, C. ; Berardesca, E. ; Rabbiosi, G. / Effects of medium-term PUVA therapy on peripheral T-lymphocyte subsets in sporiatic patients. In: Acta Dermato-Venereologica, Supplement. 1989 ; Vol. 69, No. 146. pp. 125-129.
@article{c7760bf808eb4b21a48f6bd5edb42f9f,
title = "Effects of medium-term PUVA therapy on peripheral T-lymphocyte subsets in sporiatic patients",
abstract = "Three to four months' PUVA treatment is a widely-adopted procedure to induce psoriasis remission and for the purpose of this study is called 'medium-term'. The 32 psoriatic patients considered revealed a statistically significant baseline decrease in OKT3 + (p <0.001), OKT4 + (p <0.001) and OKT8 + (p <0.001) as compared with 40 healthy controls, while OKT4/OKT8 was normal. Variance analysis within the psoriatic group failed to reveal further significant variation in the immunological parameters during the 3 months under study. Nevertheless, there was a marked trend towards a reduction in OKT4 + cells and OKT4/OKT8 as compared with baseline values after 3 months. These results suggest that 'medium-term' PUVA therapy does not statistically restore the pre-existing baseline changes in T-lymphocyte subsets of the psoriatic patients. The non-statistically significant effects as regards OKT4 + may be due to the small number of patients who reached 3 months' treatment (9 patients) but could be regarded as the first step towards the significant changes described here in long-term PUVA-treated psoriatic patients.",
keywords = "Blood T-lymphocyte subpopulations, Psoriasis, PUVA-therapy",
author = "G. Borroni and V. Brazzelli and A. Fietta and M. Gatti and M. Bellosta and G. Vignati and C. Zaccone and E. Berardesca and G. Rabbiosi",
year = "1989",
language = "English",
volume = "69",
pages = "125--129",
journal = "Acta Dermato-Venereologica, Supplement",
issn = "0365-8341",
publisher = "Society for the Publication of Acta Dermato-Venereologica",
number = "146",

}

TY - JOUR

T1 - Effects of medium-term PUVA therapy on peripheral T-lymphocyte subsets in sporiatic patients

AU - Borroni, G.

AU - Brazzelli, V.

AU - Fietta, A.

AU - Gatti, M.

AU - Bellosta, M.

AU - Vignati, G.

AU - Zaccone, C.

AU - Berardesca, E.

AU - Rabbiosi, G.

PY - 1989

Y1 - 1989

N2 - Three to four months' PUVA treatment is a widely-adopted procedure to induce psoriasis remission and for the purpose of this study is called 'medium-term'. The 32 psoriatic patients considered revealed a statistically significant baseline decrease in OKT3 + (p <0.001), OKT4 + (p <0.001) and OKT8 + (p <0.001) as compared with 40 healthy controls, while OKT4/OKT8 was normal. Variance analysis within the psoriatic group failed to reveal further significant variation in the immunological parameters during the 3 months under study. Nevertheless, there was a marked trend towards a reduction in OKT4 + cells and OKT4/OKT8 as compared with baseline values after 3 months. These results suggest that 'medium-term' PUVA therapy does not statistically restore the pre-existing baseline changes in T-lymphocyte subsets of the psoriatic patients. The non-statistically significant effects as regards OKT4 + may be due to the small number of patients who reached 3 months' treatment (9 patients) but could be regarded as the first step towards the significant changes described here in long-term PUVA-treated psoriatic patients.

AB - Three to four months' PUVA treatment is a widely-adopted procedure to induce psoriasis remission and for the purpose of this study is called 'medium-term'. The 32 psoriatic patients considered revealed a statistically significant baseline decrease in OKT3 + (p <0.001), OKT4 + (p <0.001) and OKT8 + (p <0.001) as compared with 40 healthy controls, while OKT4/OKT8 was normal. Variance analysis within the psoriatic group failed to reveal further significant variation in the immunological parameters during the 3 months under study. Nevertheless, there was a marked trend towards a reduction in OKT4 + cells and OKT4/OKT8 as compared with baseline values after 3 months. These results suggest that 'medium-term' PUVA therapy does not statistically restore the pre-existing baseline changes in T-lymphocyte subsets of the psoriatic patients. The non-statistically significant effects as regards OKT4 + may be due to the small number of patients who reached 3 months' treatment (9 patients) but could be regarded as the first step towards the significant changes described here in long-term PUVA-treated psoriatic patients.

KW - Blood T-lymphocyte subpopulations

KW - Psoriasis

KW - PUVA-therapy

UR - http://www.scopus.com/inward/record.url?scp=0024333121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024333121&partnerID=8YFLogxK

M3 - Article

VL - 69

SP - 125

EP - 129

JO - Acta Dermato-Venereologica, Supplement

JF - Acta Dermato-Venereologica, Supplement

SN - 0365-8341

IS - 146

ER -